Secher, Anna
Kelstrup, Christian D.
Conde-Frieboes, Kilian W. http://orcid.org/0000-0001-5303-4448
Pyke, Charles
Raun, Kirsten
Wulff, Birgitte S.
Olsen, Jesper V. http://orcid.org/0000-0002-4747-4938
Article History
Received: 3 October 2015
Accepted: 24 March 2016
First Online: 4 May 2016
Competing interests
: Novo Nordisk has commercial interest in neuropeptides for the treatment of diabetes and obesity. A.S., K.W.C.-F., C.P., K.R. and B.S.W. are full-time employees of Novo Nordisk and hold minor share portions as part of their employment. J.V.O. consults for and has research funding from Novo Nordisk. C.D.K. consults for Novo Nordisk.